Baseline HOMA IR and Circulating FGF21 Levels Predict NAFLD Improvement in Patients Undergoing a Low Carbohydrate Dietary Intervention for Weight Loss: A Prospective Observational Pilot Study.

Mikiko WatanabeRenata RisiElisabetta CamajaniSavina ContiniAgnese PersichettiDario TuccinardiIlaria ErnestiStefania MarianiCarla LubranoAlfredo GencoGiovanni SperaLucio GnessiSabrina Basciani

Published in: Nutrients (2020)

We suggest that patients with IR and NAFLD derive greater benefit from a VLCKD, and we propose a possible role of human FGF21 in mediating NAFLD amelioration following nutritional manipulation.

Keyphrases

weight loss
patients undergoing
endothelial cells
randomized controlled trial
bariatric surgery
induced pluripotent stem cells
roux en y gastric bypass
cross sectional
metabolic syndrome
insulin resistance
obese patients
weight gain